|
Friday, April 12 |
|
07:30-08:15 |
Hall A
E-Poster Presentations - Stroke
starts at 06:45 |
Hall B
E-Poster
Presentations - Headache & Pain |
Hall C
E-Poster
Presentations – Movement disorders & Motor Neuron disease |
Hall D
E-Poster
Presentations - Multiple Sclerosis |
| |
Hall A
Stroke |
Hall B
Headache |
Hall C
Parkinson's disease |
Hall D
Rehabilitation/
MS/
Dystonia |
|
08:30-10:30 |
|
Session 5:
Clinical Trial Endpoints; Migraine and the Cortex |
Session 9:
Outcome Parameters and Treatment of Parkinson's Disease (PD)
Supported by an unrestricted grant from UCB |
|
|
10:30-11:00 |
Coffee Break at the Exhibition Area |
|
11:00-13:00 |
Session 2:
Asymptomatic Carotid Artery Stenosis (ACAS) |
Session 6:
Migraine Therapy
Supported by an unrestricted grant from Allergan |
Partially supported by an unrestricted grant from Novartis |
Session 14
Traumatic Brain Injury
|
|
13:00-14:00 |
Lunch Break |
|
14:00-16:00 |
|
Session 7:
Stimulating the Sphenopalatine Ganglion (SPG) in Cluster Headache; Role of Neuro-Imaging in Headache Management |
The Complex Space of PD
Supported by an unrestricted grant from
Britannia Pharmaceuticals |
Session 15
Can the Natural History of MS be Modified?
|
|
16:00-16:30 |
Coffee Break at the Exhibition Area |
|
16:30-18:30 |
Supported by an unrestricted grant from Takeda Pharmaceuticals
|
Session 8:
Sleep and Migraine |
Treatment of Complications in PD
Partially supported by an unrestricted grant from H.Lundbeck and Teva Pharmaceutical Industries |
Session 16
Treatment of Dystonia
Partially supported by an unrestricted grant from Winston and Strawn
|
